Genome Web Breaking News
- In Brief This Week: Novogene, Hologic, Agilent, Diagenode
- Spontaneous Preterm Birth Clues Identified in Cervicovaginal Microbiome
- Germany Plans Limited Coverage of NIPT for Certain High-Risk Pregnancies
- Bruker TB Test, PCR Platform Receives CE-IVD Mark
- Single-Cell Sperm Sequencing Reveals New Details About Recombination
Stat
- Opinion: India should heed a teenager’s historic fight for lifesaving tuberculosis treatment
- Opinion: Ending tuberculosis: we can get there with a new roadmap
- STAT Plus: Biogen-Eisai partnership may be hitting a rough patch following Alzheimer’s drug blowup
- STAT Plus: Kentucky probes pharmacy benefit managers for allegedly overcharging state Medicaid
- STAT Plus: J&J’s new esketamine drug for depression may solve an unmet need, but may not be cost-effective
NYT science news
- Depressed and Anxious? These Video Games Want to Help
- Medicare for All Would Abolish Private Insurance. ‘There’s No Precedent in American History’
- The Northern Lights Are Expected in the Northern U.S., but Don’t Get Too Excited
- Under the Influence of a ‘Super Bloom’
- Tyson Recalls 69,000 Pounds of Chicken Strips After Metal Fragments Are Found
Xconomy news
- Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs
- Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
- Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed
- CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
- Corza Health Emerges Led by Former NuVasive, GreatCall Executives
Fierce Biotech
- More bad Alzheimer’s news as FDA device panel is not persuaded by Neuronix’s TMS study
- A smart toilet seat to detect heart failure?
- Turning Point Therapeutics eyes $100M IPO to propel treatment for drug-resistant tumors
- Impulse Dynamics wins FDA approval for breakthrough heart implant
- CRISPR diagnostic maker Sherlock Biosciences says the game’s afoot with $35M launch
Fierce Medical Devices
- More bad Alzheimer’s news as FDA device panel is not persuaded by Neuronix’s TMS study
- A smart toilet seat to detect heart failure?
- Impulse Dynamics wins FDA approval for breakthrough heart implant
- Fresenius forms new global medical office to coordinate R&D and practice sharing
- FDA sends warning letters to breast implant manufacturers as safety probe continues